Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Biohaven Pharmaceutical Q2 EPS $(3.82) Down From $(2.62) YoY

Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(3.82) per share. This is a 45.8 percent decrease over losses of $(2.62) per share from the same period last year.
byBenzinga Newsdesk
August 5, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(3.82) per share. This is a 45.8 percent decrease over losses of $(2.62) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts